Pulmonary Hypertension Trial, Recruiting (NCT04901884)

Pulmonary Hypertension Trial, Recruiting NCT04901884 Sponsor: University Health Network, Toronto Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT04901884 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have a chest tumour that has been confirmed by biopsy or other clinical assessment, and is planned to be treated with radiation therapy (with or without chemotherapy)
People whose planned radiation treatment is expected to expose the heart to a radiation dose of at least 25 Gray (a unit used to measure radiation)
Women of childbearing age who have had a negative pregnancy test (urine or blood) within the two weeks before the imaging scan
People who are able to give written consent to take part in all parts of the study, which includes a heart scan (PET/MR imaging), blood samples for metabolic analysis, and circulating DNA testing

Who may not be able to join:

People who have a medical reason they cannot have an MRI scan, based on the guidelines used at the trial site
People who have a medical reason they cannot receive a Gadolinium injection (a contrast dye used during MRI scans), based on the guidelines used at the trial site
People who are unable to lie flat on their back for at least 45 minutes
People who are pregnant or breastfeeding
People with a known allergy or sensitivity to 18F-FDG (a radioactive substance used in PET scans)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrick Veit-Haibach, MD, University Health Network, Toronto

Phone: 416-340-4800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04901884

Sponsor: University Health Network, Toronto

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 416-340-4800

More information: https://clinicaltrials.gov/study/NCT04901884

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have a chest tumour that has been confirmed by biopsy or other clinical assessment, and is planned to be treated with radiation therapy (with or without chemotherapy)
People whose planned radiation treatment is expected to expose the heart to a radiation dose of at least 25 Gray (a unit used to measure radiation)
Women of childbearing age who have had a negative pregnancy test (urine or blood) within the two weeks before the imaging scan
People who are able to give written consent to take part in all parts of the study, which includes a heart scan (PET/MR imaging), blood samples for metabolic analysis, and circulating DNA testing

Who may not be able to join:

People who have a medical reason they cannot have an MRI scan, based on the guidelines used at the trial site
People who have a medical reason they cannot receive a Gadolinium injection (a contrast dye used during MRI scans), based on the guidelines used at the trial site
People who are unable to lie flat on their back for at least 45 minutes
People who are pregnant or breastfeeding
People with a known allergy or sensitivity to 18F-FDG (a radioactive substance used in PET scans)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Health Network, Toronto

Registry

ClinicalTrials.gov

Start date

1 June 2021

Est. completion

1 June 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change of FDG uptake of heart; Change of FDG uptake of lungs; Change of the heart function; Change of the lung perfusion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov